MRNA is trading 3.03% down at $29.49, aligning with broader market weakness observed across major indices.
- Broader market indices saw significant drops, with the S&P 500 falling 0.73%, NASDAQ 0.76%, and Dow 0.62%.
- No company-specific news or events were reported for the day.
- Options data signals bearish sentiment regarding MRNA's mRNA platform viability, driven by sector rotation pressures.